Clinical Trials Logo

Clinical Trial Summary

The goal of this randomized controlled feasibility study was to evaluate the feasibility of preoperative inspiratory muscle training in patients undergoing surgery because of peritoneal metastases. The main questions it aimed to answer was how feasible the intervention is regarding process and scientific feasibility as defined by Thabane et al 2010. Participants in the intervention group were using a handheld device to increase their inspiratory muscle strength prior to surgery and researchers compared this group to a control group who were offered a sham treatment.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05665257
Study type Interventional
Source Uppsala University
Contact
Status Completed
Phase N/A
Start date November 2016
Completion date September 2020

See also
  Status Clinical Trial Phase
Recruiting NCT03422432 - Prophylactic HIPEC for Colorectal Cancers at High Risk of Developing Peritoneal Metastases N/A
Not yet recruiting NCT06295094 - The Efficacy of PIPAC and Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients. Phase 2
Recruiting NCT05056389 - Normothermic Intraperitoneal Chemotherapy - Long Term in Peritoneal Metastases From Colorectal Cancer (NIPEC-OXA) Phase 1
Withdrawn NCT03682744 - CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC) Phase 1
Recruiting NCT05623787 - Diagnostic Value of Diffusion-weighted Magnetic Resonance in High-risk Colorectal and Appendiceal Neoplasms N/A
Not yet recruiting NCT05095467 - HIPEC-AS in Patients With Peritoneal Metastasis of the Stomach or Esophagogastric Junction Phase 2
Completed NCT04083547 - Circulating Tumour Cells in Patients With Peritoneal Metastases
Recruiting NCT06216561 - Intraperitoneal LSTA1 in CRS-HIPEC Phase 1
Recruiting NCT05277766 - Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer Phase 1
Not yet recruiting NCT05318794 - Neoadjuvant Systemic and Peritoneal Chemotherapy for Advanced Gastric Cancer Phase 2
Recruiting NCT05581719 - A Phase 1/2a Study Evaluating Allocetra-OTS as Monotherapy or in Combination With Anti-PD-1 Therapy for the Treatment of Advanced Solid Tumor Malignancy Phase 1/Phase 2
Recruiting NCT05379790 - Concomitant Intraperitoneal and Systemic Chemotherapy in Patients With Extensive Peritoneal Carcinomatosis of Gastric Origin Phase 1
Recruiting NCT04956068 - PIPAC for Peritoneal Metastases Phase 1
Recruiting NCT05204173 - Efficacy and Safety of Sintilimab Combined Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal Metastasis Phase 2
Recruiting NCT04861558 - Efficacy of Hyperthermic Intraperitoneal Chemotherapy Phase 3
Recruiting NCT05340569 - Diagnostic Value of DWI-MRI for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma. N/A
Recruiting NCT03834272 - Feasibility of the LUM Imaging System for Peritoneal Surface Malignancies Phase 1/Phase 2
Not yet recruiting NCT04744688 - Changes in Coagulation in Colorectal Cancer Patients Undergoing Surgical Treatment
Completed NCT03733184 - Development of an IDEAL Framework to Standardise Cytoreductive Surgery for Colorectal Peritoneal Metastases
Recruiting NCT05755672 - On-treatment Biomarkers in Metastatic Colorectal Cancer for Life